Recently, Lukang pharma successfully passed the re-certification of the National Enterprise Technology Center with "excellent" results. Since the company passed the national enterprise technology center certification firstly in 2011, the company has always adhered to independent research and development, scientific and technological innovation, continuously increased R&D investment and talent introduction, continued to maintain over 6% R&D investment every year, and strengthened cooperation with domestic and foreign scientific research institutions and universities to promote new product development and transformation of scientific and technological achievements. The company will further strengthen its R&D innovation capabilities, and make new contributions to promoting the high-quality development of the industry and the company.